Suchergebnisse - "Moreno, Lorena Ortega"

PubPharm (5)

1

Serum Orotidine : A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies

enthalten in: Diabetes care | 2022

von Shah, H. | Moreno, L. | Morieri, M. | +9

2

Metabolomics study of COVID-19 patients in four different clinical stages

enthalten in: Scientific reports | 2022

von Valdés, A. | Moreno, L. | Rello, S. | +3

3

Lipidomics as Tools for Finding Biomarkers of Intestinal Pathology : From Irritable Bowel Syndrome to Colorectal Cancer

enthalten in: Current drug targets | 2022

von Moreno, L. | Sánchez, P. | Abalo, R.

4

Lipidomics as Tools for Finding Biomarkers of Intestinal Pathology: From Irritable Bowel Syndrome to Colorectal Cancer

enthalten in: Current drug targets | 2022

von Moreno, L. | Sánchez, P. | Abalo, R.

5

Serum resistin and glomerular filtration rate in patients with type 2 diabetes

enthalten in: PloS one | 2015

von Moreno, L. | Salvemini, L. | Mendonca, C. | +6

ErratumIn: PLoS One. 2015;10(4):e0127250. - PMID 25905777

1
[1]